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Dedicated to the memory of Jean-Pierre PerichetAbstract In Drosophila, the tumor suppressor Scribble is local-
ized at the septate junctions of epithelial cells. Its mammalian
homologue, hScrib, is a basolateral protein likely associated to
proteins of the cell–cell junctions. We report the direct interac-
tion between hScrib and ZO-2, a junction-associated protein.
This interaction relies on two PDZ domains of hScrib and on
the C-terminal motif of ZO-2. Both proteins localise at cell–cell
junctions of epithelial cells. A point mutation in the LRR of
hScrib delocalises the protein from the plasma membrane and
abrogates the interaction with ZO-2 but not with bPIX. Tyrosine
phosphorylation of hScrib does not impair the interaction with
ZO-2. We show a direct link between two junctional proteins
that are down-regulated during cancer progression.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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domain1. Introduction
The diﬀerentiation of epithelial cells is characterized by the
establishment of apico-basal polarity. In these cells, the apical
surface is in contact with ﬂuids while the lateral and basal
membranes are in contact with the neighbouring cells and
the extracellular matrix, respectively. One of the hallmarks of
polarized epithelial cells is the presence of specialized junctions
that tightly control epithelial homeostasis. Tight junctions
(TJs) separate apical and lateral compartments and act as a
fence and a barrier to prevent the diﬀusion of proteins and lip-
ids, and regulate the paracellular movement of molecules [1].
TJs are lying apical to the adherens junctions, and comprise
transmembrane (claudins, occludins, crumbs, etc.) and cyto-
plasmic (ZO-1, 2 and 3, AF-6/Afadin, etc.) molecules impor-
tant for cell diﬀerentiation.
ZO-2 belongs to the membrane-associated guanylate kinase
(MAGUK) protein family and has been ﬁrst described as a TJ-
associated cytoplasmic protein [2,3]. Like other MAGUKs,
ZO-2 contains three PDZ domains, a SH3 domain, and aAbbreviations: TJs, tight junctions; MAGUK, membrane-associated
guanylate kinase; LRR, leucine rich repeat; LAP, LRR and PDZ;
LAPSD, LAP speciﬁc domain; MDCK, Madin Darby canine kidney
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acts with several components of the TJs, including ZO-1
[2,5], 4.1R protein [6], cingulin [7], occludin [5], claudins [8]
and actin [9]. Association between ZO-2 and a-catenin [5],
an adherens junction-associated protein, suggests the distribu-
tion of this protein at the lateral membrane. Like ZO-1 [10,11]
and LIN-2 [12] MAGUKs, ZO-2 localises in the nucleus of
sparse epithelial cells [13,14] where it regulates gene transcrip-
tion through its association with transcription factors such as
JUN, FOS, and C/EBP [15]. Implication of ZO-2 in cancer is
supported by several studies. For instance, one of ZO-2 iso-
forms is lacking in pancreatic adenocarcinoma [16]. Further-
more, overexpression of ZO-2 inhibits cell transformation
induced by the E4 oncogenic determinant of type 9 adenovirus,
polyomavirus middle T proteins and activated RasV12 [17].
Studies in Drosophila have characterized homologues of
ZO-2 as potent tumor suppressors [18].
Members of the LRR and PDZ (LAP) protein family are
regulators of epithelial cell polarity [19–22]. Among this fam-
ily, hScrib has similar functions to its Drosophila homologue
[23–25]. Disruption of hScrib in mice provokes severe neural
tube defects [26,27] as well as defects of the orientation of
hair cell stereociliary bundles within the cochlea, due to im-
paired planar cell polarity [28]. In humans, the expression
of hScrib decreases during the progression of uterine cer-
vix cancers and in lobular breast cancers [29,30]. Therefore,
like ZO-2, hScrib is believed to participate to tumorigenic
processes.
We recently characterized a bPIX-GIT1 complex bound to
the PDZ domains of hScrib [31]. hScrib has four PDZ domains
that interact with multiple partners [32]. We used these do-
mains to pull-down novel interactors and identiﬁed ZO-2 as
a new partner for hScrib by mass spectrometry analysis. We
describe here the interaction between these two potential
tumor suppressors in epithelial cells.2. Materials and methods
2.1. Cell culture
COS-7 and Madin Darby canine kidney II (MDCKII) cells were
grown in DMEM containing 10% FCS, 100 U/ml penicillin, and
100 mg/ml streptomycin sulfate. MCF10.2A were grown in Hams
F12/DMEM containing 5% horse serum, 2 mM glutamine, 10 lg/ml
insulin, 20 ng/ml EGF, 100 ng/ml Cholera toxin, 500 ng/ml hydrocor-
tisone, 100 U/ml penicillin and 100 mg/ml streptomycin sulfate. Cell
transfections were performed using polyFECT (Qiagen) reagent
according to the manufacturers recommendations. MDCKII cells
stably expressing GFP-hScrib fusions were previously described [19].
Cells were starved in DMEM/0.5% FCS for 5 h prior to activation with
200 lM sodium pervanadate in complete medium.blished by Elsevier B.V. All rights reserved.
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HA-ZO-2 was expressed in mammalian cells using the pGW1-CMV
vector kindly provided by Dr. Ronald T. Javier (Baylor College of
Medicine, Houston, Texas). HA-Lano was expressed using
pCDNA3-HA vector. pGW1-CMV-HA-ZO-2.DTEL was obtained
using the QuickChangee mutagenesis kit (Stratagene). The GFP-
hScrib constructs were previously described [31].
2.3. Biochemical procedures
Cells were rinsed twice in cold PBS, and lysed in buﬀer containing
50 mMHEPES, pH 7.5, 1 mM EGTA, 150 mMNaCl, 1.5 mMMgCl2,
10% glycerol, 1%Triton X-100, supplemented with 1 mM PMSF,
1 mM orthovanadate, 10 nM aprotinine, and 1 lM leupeptine. Tri-
ton-soluble proteins were recovered in the supernatant of a 20 min cen-
trifugation at 13 000 · g and 4 C. GST pull-down, two-hybrid assays,
immunoprecipitations and Western blots were performed as previously
described [20].
2.4. Mass spectrometry
For mass spectrometry analyses, protein complexes were separated
in a Xcell sure locke electrophoresis unit with 4–12% bis–tris gradient
pre-cast NuPAGEe gels in MOPS buﬀer according to the manufac-
turers instructions (Invitrogen). Silver stained samples were prepared
and digested according to Shevchenko et al. [33]. Mass spectrometry
analyses were performed using MALDI-TOF by Ultraﬂex Bruker
instrument (Bruker Daltonique). Protein identiﬁcation was carried
out with Mascot software (Matrixscience Inc.).
2.5. Immunoﬂuorescence and confocal microscopy
MDCKII cells were grown on Transwelle ﬁlters, washed twice in
PBS 0.1 mM Ca2+/1 mM Mg2+, and ﬁxed for 20 min in 4% parafor-
maldehyde at 4 C. Cells were permeabilized during 5 min with 0.5%
Triton X-100 at RT, and blocked in 0.25% gelatine for 1 h at RT. Anti-
bodies diluted in the blocking buﬀer were incubated overnight at 4 C.
After 4 washes of 15 min cells were incubated for 1 h at RT with sec-
ondary antibodies coupled to ﬂuorescent probes. Cells were washed
and ﬁlters were mounted in Dako (Jackson laboratories) for confocal
microscopy analyses.Fig. 1. ZO-2 is a binding partner for the PDZ domains of hScrib. (A) Silver-
GST fusion proteins encompassing the PDZ domains of hScrib. (B) Peptide s
mass spectrometry analysis. Note the canonical C-terminal PDZ binding mo2.6. Antibodies
Polyclonal anti-ZO-2 antibody is from Zymed laboratories.
Polyclonal anti-bPIX antibody is from Chemicon. Monoclonal anti-
GFP and anti-HA antibodies are from Roche. Monoclonal anti-
b-catenin antibody is from BD Bioscience. Monoclonal antibody
directed against hScrib and Lano (8.1.1) was previously described
[20]. Polyclonal-anti-GIT1 antibody was kindly provided by Dr.
Richard T. Premont [34]. Monoclonal anti-phosphotyrosine antibody
is from Upstate Biotechnology. Secondary antibodies coupled to
horseradish peroxidase used for Western blotting are from DakoCy-
tomation and Jackson laboratories. Secondary antibodies coupled to
alexa ﬂuorophores for immunoﬂuorescent experiments are from
Molecular Probes.3. Results
3.1. Identiﬁcation of ZO-2 as a new partner of the PDZ domains
of hScrib
To look for new binding partners of the PDZ domains of
hScrib (Fig. 1A), we carried out GST pull-down experiments
using non-transformed mammary epithelial MCF10.2A cell
extracts and puriﬁed GST-hScrib PDZ proteins. Bound pro-
teins to the GST were separated on SDS–PAGE, silver stained
and identiﬁed by mass spectrometry. GST-hScrib PDZ and
GST-hScrib (3 + 4) domains reproducibly precipitated a
175 kDa protein (red arrowheads). We identiﬁed this band as
ZO-2 (Fig. 1B). A 80-kDa protein (green arrowheads) was also
puriﬁed by GST-hScrib PDZ, (1 + 2), and GST-hScrib (3 + 4)
and was identiﬁed as bPIX, a known partner for hScrib [31].
Interaction between hScrib and ZO-2 was conﬁrmed by GST
pull-down and Western blotting using anti-ZO-2 antibody
(Fig. 2B). No interaction was found with GST and GST-
LIN-2 PDZ.stained protein gel after pull-down assays on MCF10.2A extracts using
equence of ZO-2 showing the peptide coverage (red sequence) from the
tif at the end of ZO-2 sequence (TEL motif).
Fig. 2. The PDZ3 and PDZ4 domains of hScrib interact with ZO-2. (A) Schematic representation of hScrib constructs (Grey: LRR domain; Red:
LAPSDA; Yellow: LAPSD B; Blue: PDZ domains). (B) Pull-down assays on MCF10.2A extracts using GST fusion proteins encompassing the PDZ
domains. Note that the 30 kDa GST is not seen in Red Ponceau staining. (C) Anti-GFP immunoprecipitations were carried out using extracts of
MDCKII cells expressing GFP or GFP-hScrib PDZ. Bound proteins were detected with the mentioned antibodies.
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Interaction was conﬁrmed using MDCKII cells expressing
GFP or GFP-hScrib PDZ. Proteins were immunoprecipitated
with anti-GFP and detected with anti-ZO-2 antibody (Fig.
2C). ZO-2 co-immunoprecipitated with GFP-hScrib but not
with GFP. As expected [31], the bPIX/GIT1 complex was also
precipitated by GFP-hScrib PDZ. Then, COS-7 cells were co-
transfected with HA-ZO-2 and GFP-hScrib. GFP-hScrib was
immunoprecipitated with anti-hScrib antibody and bound pro-
teins were recognized with anti-HA antibody (Fig. 3). HA-ZO-
2 (lane 1), but not HA-Lano (lane 2) [20], was associated with
GFP-hScrib.
3.3. Interaction between hScrib and ZO-2 is mediated by the
PDZ domains of hScrib and the C-terminal motif of ZO-2
The mapping of the interaction was carried out by co-
expressing mutants of GFP-hScrib and HA-ZO-2 in COS-7
cells. We focused on the PDZ binding site present at the car-Fig. 3. ZO-2 and hScrib interact in living cells. GFP-hScrib was co-
expressed in COS-7 cells with HA-ZO-2 or HA-Lano. Immunopre-
cipitations were carried out with anti-hScrib antibody (TL: Total
Lysate).boxy-terminus of ZO-2 (TEL motif) likely involved in the
interaction with the PDZ of domain of hScrib [32]. HA-ZO-
2 or HA-ZO-2 lacking the PDZ binding site (HA-ZO-2.DTEL)
were co-expressed with GFP-tagged hScrib, hScrib.DPDZ,
hScribPL, hScrib1-724, or hScrib717-1630 (Fig. 2A and Fig. 4A).
Immunoprecipitations were performed using anti-GFP anti-
body and bound proteins were detected using anti-ZO-2 anti-
body. HA-ZO-2 and HA-ZO-2.DTEL were equally expressed
(data not shown). As shown in Fig. 4A, removal of the PDZ
domains (GFP-hScrib.DPDZ) abrogated the interaction with
ZO-2 (lane 2). Furthermore, the amino-terminus of hScrib
did not interact with ZO-2 (lane 4) in contrast to the car-
boxy-terminus (lane 5). HA-ZO-2.DTEL was not precipitated
by GFP-hScrib conﬁrming that the TEL motif is required
for the interaction (lane 6). Mutation of proline 305 in the leu-
cine rich repeat (LRR) to leucine (PL mutant) precludes the
retention of hScrib at the plasma membrane [31,35]. We ob-
served a decreased interaction between GFP-hScribPL and
HA-ZO-2, while the binding between GFP-hScribPL and bPIX
was not aﬀected (Fig. 4A, lane 3 and Fig. 5B, lane 4). A yeast
two-hybrid assay conﬁrmed that the interaction between
hScrib and ZO-2 is direct and mediated by the PDZ domains
and the TEL motif (Fig. 4B).
3.4. Tyrosine phosphorylation of hScrib does not impair the
interaction with ZO-2
Examination of the carboxy-terminus of ZO-2 shows the
presence of a tyrosine residue at position 5 from the car-
boxy-terminal leucine. Transfected COS-7 cells were stimulated
with sodium pervanadate and co-immunoprecipitations were
performed with anti-GFP antibody.We observed a strong tyro-
sine phosphorylation of GFP-hScrib proteins in these lysates
(red dots in right panel of Fig. 5A) while ZO-2 was very weakly
phosphorylated. GFP alone was not tyrosine phosphorylated
Fig. 4. Mapping of the hScrib-ZO-2 interaction. (A) GFP-hScrib constructs were co-expressed in COS-7 cells with HA-ZO-2 or HA-ZO-2.DTEL
prior to immunoprecipitation with anti-GFP antibody and Western blot with the mentioned antibodies. (B) A yeast two-hybrid assay was carried out
using hScrib constructs as preys (GAL4-AD), and C-terminal regions of ZO-2 and bPIX as baits (LexA-BD). Positivity for b-galactosidase test and
growth on selective medium complemented with 50 mM 3-AT were annotated (+). Negative reactions were annotated ().
Fig. 5. Tyrosine phosphorylation of hScrib does not impair the interaction with ZO-2. COS-7 cells co-expressing GFP-hScrib constructs and HA-
ZO-2 or HA-ZO-2.DTEL were activated with sodium pervanadate. Immunoprecipitations performed with anti-GFP antibody were revealed with
anti-phosphotyrosine antibody (A) or with the mentioned antibodies (B). The lower band detected with anti-ZO-2 antibody in B may represent a
byproduct due to overexpression of ZO-2. In A, red dots point phosphorylated GFP-hScrib proteins and a black arrowhead points to the tyrosine
phosphorylated GIT1 protein. Identity of GIT1 was conﬁrmed by Western blot (data not shown).
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conserved upon tyrosine kinase activation (Fig. 5B). GIT1,
but not bPIX, was strongly tyrosine phosphorylated and still
interacted with hScrib (Fig. 5A and data not shown).3.5. hScrib and ZO-2 partially co-localise in MDCKII cells
We looked for the subcellular localisation of ZO-2 and
hScrib in epithelial cells. We performed immunostaining andconfocal analysis of unpolarized and polarized MDCKII cells
and detected a partial co-localisation between GFP-hScrib and
ZO-2 (or ZO-1) at the cell–cell junctions of unpolarized cells
(Fig. 6A). hScrib did not co-localise with the TJ markers
ZO-1 or ZO-2 in polarized MDCK (Fig. 6B) cells whereas it
co-localized with b-catenin, a marker of adherens junctions
(data not shown) [19]. Therefore, the hScrib-ZO-2 interaction
likely takes place at the cell–cell junctions before segregation
of ZO-2 to the TJs.
Fig. 6. hScrib and ZO-2 partially colocalize at cell–cell junctions. Confocal analyses of unpolarized (A) or polarized (B) MDCKII GFP-hScrib
expressing cells immunostained with anti-ZO-1 or ZO-2 antibodies (red). In contrast to ZO-1 and ZO-2, hScrib was absent from the nucleus in
unpolarized cells (A). XY (A and B) and XZ (B) sections are presented here.
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Genetic studies carried out in Drosophila identiﬁed scribble
and dlg as potent neoplastic tumor suppressor genes [18,23].
In humans, loss of their homologues has been associated to
progression of mammary, uterine and pancreatic cancers
[16,17,30]. We previously demonstrated that hScrib belongs
to a signalling complex comprising bPIX and GIT1, two regu-
lators of small GTPase activities [31]. Furthermore, hScrib is
associated to the basolateral membrane of epithelial cells by
its LRR domain, suggesting an association with junctional
proteins [19].
Here, we identify ZO-2 as a protein associated to hScrib at
the cell–cell junctions. We show that this interaction relies on
the PDZ3 and PDZ4 domains of hScrib and on the carboxy-
terminus of ZO-2. Interestingly, PDZ1 and PDZ2 have the
ability to interact with bPIX, but not with ZO-2, demonstrat-
ing that the PDZ domains of hScrib have diﬀerent binding
speciﬁcities (Fig. 2B).
We could recover the interaction between epitope-tagged
proteins in living cells and demonstrated that it takes place
at the cell–cell junctions of unpolarized epithelial cells (Fig.
6). We nevertheless failed to obtain convincing co-immunopre-
cipitation results with endogenous proteins. Interestingly, a
point mutation in the LRR of hScrib (hScribPL mutant), which
delocalises the protein from the plasma membrane [19,31,35],
impaired the interaction with ZO-2 but not with bPIX (Fig.
4A and Fig. 5B). Accordingly, bPIX co-immunoprecipitates
with hScrib in the cytosolic fraction of epithelial cells (data
not shown). From these results, we infer that the localisation
of hScrib at the cell periphery is important for the interaction
with ZO-2.
Tyrosine phosphorylation of hScrib did not modify its abil-
ity to interact with ZO-2 or bPIX (Fig. 5). While hScrib and
GIT1 are heavily phosphorylated on tyrosine residues, we ob-
served a very poor tyrosine phosphorylation of ZO-2. There-
fore, it remains unknown if the carboxy-terminal tyrosine
residue of ZO-2 is phosphorylated. Accordingly, previous
studies have described ZO-2 as a target for serine and threo-
nine, but not for tyrosine kinases [36,37].Delocalisation of ZO-2 from the cell–cell junctions alters the
integrity of epithelial monolayers [36,37]. Overexpression of
wild type or mutant hScrib or knock-down of hScrib by siR-
NA did not aﬀect the subcellular localisation of ZO-2 and
had no incidence on the morphology of MDCKII cells (data
not shown). Functional redundancy within the LAP and ZO
families may explain this result.
We have recently observed that, in breast cancers, most lob-
ular tumors do not express hScrib and E-cadherin while ductal
tumors have a less frequent down-regulation of hScrib [19]. It
will be interesting to evaluate the expression of ZO-2 in these
tumors to see if it correlates with the expression pattern of
hScrib. Additional functional assays will also analyze the role
of hScrib-ZO-2 complex with regards to cell proliferation and
transformation.
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